These results were similar across various analyses, which will be summarized in the following
CagriSema represents the next step for patients who need greater weight loss than semaglutide al
The pivotal PIONEER and SUSTAIN clinical trial programs demonstrated the efficacy of oral and subcutaneous semaglutide across different populations, compared with placebo or other glucose-lowering medications
The decision framework: a structured approach for breastfeeding mothers Given the complexity of this decision, a structured approach can help mothers and their physicians evaluate whether GLP-1 therapy during breastfeeding is appropriate for their specific situation
having had heart surgery or other heart problems Congenital heart disease Other heart conditions, such as Wolff-Parkinson-White syndrome Chronic lung disease Excessive caffeine intake Excessive alcohol intake Smoking or other tobacco products Drug misuse, including cocaine and methamphetamines Pregnancy Menopause High blood pressure Certain over-the-counter medications, including those for asthma, colds and allergies What are the symptoms of SVT/PSVT